# Kesmalea Therapeutics (Kesmalea Therapeutics Limited) Private limited company registered in London, classed under “Research and experimental development on biotechnology”. - Company number: 12961631 - Status: Active - Type: Private limited company - Incorporated: 20 October 2020 - Registered office: Cannon Place, 78 Cannon Street, London, EC4N 6AF - Location: London - Activity: Research and experimental development on biotechnology ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Kesmalea Therapeutics do? Private limited company registered in London, classed under “Research and experimental development on biotechnology”. ### How much turnover does Kesmalea Therapeutics make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/kesmalea-therapeutics-12961631 ### Is Kesmalea Therapeutics profitable? Kesmalea Therapeutics's profit isn't public: small companies may file without a profit and loss account. ### How many people work at Kesmalea Therapeutics? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/kesmalea-therapeutics-12961631 ### Who runs and owns Kesmalea Therapeutics? Its directors are Timothy Piers Clackson, Clive Dix, Justian Craig Fox, Robert Steven Johnson, Raghd Rostom and 1 more. Its owners are shown to subscribers. ### Where is Kesmalea Therapeutics based? Its registered office is Cannon Place, 78 Cannon Street, London, EC4N 6AF, in London. ### When was Kesmalea Therapeutics founded? Kesmalea Therapeutics Limited was incorporated on 20 October 2020. ### Is Kesmalea Therapeutics still trading? The register lists Kesmalea Therapeutics Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-11-02: Appointment of Mr Owen Philip Smith as a director on 19 October 2026 - 2026-11-02: Termination of appointment of Harry Finch as a director on 19 October 2026 - 2026-11-02: Termination of appointment of Stephen Molumby as a director on 19 October 2026 - 2026-09-01: Registered office address changed from 2nd Floor, 8 Bloomsbury Street London WC1B 3SR England to Cannon Place 78 Cannon Street London EC4N 6AF on 1 September 2026 - 2026-05-13: Termination of appointment of Richard Francis Wooster as a director on 6 May 2026 - 2026-05-13: Termination of appointment of Magdalena Anna Jonikas as a director on 6 May 2026 - 2026-05-13: Appointment of Mr Stephen Molumby as a director on 6 May 2026 - 2026-04-10: Change of share class name or designation (and 3 more like it since 6 November 2020) - 2025-12-22: Accounts for a small company made up to 31 March 2025 - 2025-11-10: Appointment of Dr Raghd Rostom as a director on 6 November 2025 - 2025-10-30: Statement of capital following an allotment of shares on 23 October 2025 · GBP 41,032.86625 (and 7 more like it since 6 November 2020) - 2025-10-28: Director's details changed for Harry Finch on 28 October 2025 - 2025-05-14: Appointment of Dr Timothy Piers Clackson as a director on 9 May 2025 - 2025-04-07: Termination of appointment of Raghd Rostom as a director on 1 April 2025 - 2024-12-17: Accounts for a small company made up to 31 March 2024 - 2024-11-23: Particulars of variation of rights attached to shares - 2024-11-07: Appointment of Mr Robert Steven Johnson as a director on 4 November 2024 - 2024-10-11: Appointment of Mr Richard Wooster as a director on 4 October 2024 - 2024-09-04: Change of details for Syncona Limited as a person with significant control on 3 September 2024 - 2024-06-04: Appointment of Dr Raghd Rostom as a director on 30 May 2024 - 2024-05-03: Termination of appointment of Malcolm Weir as a director on 19 April 2024 - 2024-03-25: Termination of appointment of Madeleine Elizabeth Kennedy as a secretary on 25 March 2024 - 2023-12-29: Total exemption full accounts made up to 31 March 2023 - 2023-09-18: Satisfaction of charge 129616310001 in full - 2023-09-15: Registration of charge 129616310002, created on 7 September 2023 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/kesmalea-therapeutics-12961631